Standard BioTools Inc (NASDAQ:LAB) does about 2.23M shares in volume on a normal day but saw 1847856 shares change hands in Monday trading. The company now has a market cap of 949.96M USD. Its current market price is $2.48, marking a decrease of -1.20% compared to the previous close of $2.51. The 52 week high reached by this stock is $3.16 whilst the lowest price level in 52 weeks is $1.46.
Standard BioTools Inc (LAB) has a 20-day trading average at $2.60 and the current price is -21.52% off the 52-week high compared with 69.86% distance from its 52-week low. The 50-day simple moving average of the closing price is $2.61 and its 200-day simple moving average is $2.43. If we look at the stock’s price movements over the week, volatility stands at 4.47%, which increases to 5.53% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 43.09 to suggest the stock is neutral.
The consensus objective for the share price is $3.58, suggesting that the stock has a potential upside of 30.73% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on April 16, 2024 when TD Cowen initiated the stock to “Buy” and issued a price target of $3.50. KeyBanc Capital Markets initiated its price target at $4.
Its price is 12.22% year-to-date and 63.16% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at 0 and 0 for whole year.
To reach the target analysts have set, the stock logically needs to grow 30.73 percent from here.
The company has a return on investment of -37.79% and return on equity of -37.99%. The beta has a value of 1.68. Price to sales ratio is 8.93.
